A Study of Cisapride in Premature Infants With Feeding Problems

NCT01281566 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

8

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor request

Conditions

Infant, Premature
Infant, Newborn

Interventions

DRUG: Placebo
DRUG: Cisapride

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.